Abrogation of glucocorticoid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gamma.
| dc.contributor.author | Waseem, Y. Almawi | |
| dc.contributor.author | Lipman, ML | |
| dc.contributor.author | Stevens, AC | |
| dc.contributor.author | ETAL.. | |
| dc.date.accessioned | 2022-02-17T13:48:50Z | |
| dc.date.accessioned | 2023-08-19T08:53:10Z | |
| dc.date.available | 2022-02-17T13:48:50Z | |
| dc.date.available | 2023-08-19T08:53:10Z | |
| dc.date.issued | 1991-05 | |
| dc.description.abstract | Glucocorticoids (GCS) inhibit the transcription of multiple activation-associated cytokine genes. By Northern blot analysis now we demonstrate that antiproliferative concentrations of dexamethasone and 6 alpha-methylprednisolone block mitogen-induced IL-2 gene expression in human peripheral blood mononuclear leukocytes in a concentration-dependent fashion. In addition, using a mitogen-induced proliferation assay of human peripheral blood mononuclear leukocytes, we show that GCS-mediated anti-proliferative effects are not blocked by rIL-1, rIL-2, rIL-3, rIL-4, rIL-5, rIL-6, rTNF-alpha, rTNF-beta, and rIFN-gamma, individually at 1 to 1000 U/ml, but are totally abrogated, in a concentration-dependent fashion, by the combination of rIL-1, rIL-6, and rIFN-gamma (25 to 50 U/ml for each cytokine). Thus, blockade of cytokine expression is the primary mechanism by which GCS inhibit mitogen-driven and alloantigen-induced T cell proliferation. The immunosuppressive effects of GCS are almost certainly exacted at the level of cytokine gene transcription. | en_US |
| dc.identifier.citation | Almawi, W. Y., Lipman, M. L., Stevens, A. C., Zanker, B., Hadro, E. T., & Strom, T. B. (1991). Abrogation of glucocorticoid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gamma. The Journal of Immunology, 146(10), 3523-3527. | en_US |
| dc.identifier.uri | https://edms.wexl.in/handle/1/2684 | |
| dc.language.iso | en | en_US |
| dc.publisher | American Association of Immunologists | en_US |
| dc.subject | Glucocorticoids | en_US |
| dc.subject | Blood mononuclear | en_US |
| dc.subject | Cytokine | en_US |
| dc.subject | Cell proliferation | en_US |
| dc.subject | Immunosuppressive | en_US |
| dc.title | Abrogation of glucocorticoid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gamma. | en_US |
| dc.title.alternative | The Journal of Immunology | en_US |
| dc.type | Article | en_US |
Files
License bundle
1 - 1 of 1
